Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures-Reference-Cited by-同舟云学术

Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures

Published:2022-09-23 Issue:10 Volume:42 Page:780-791
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Bradshaw Paige Garber¹²^ORCID,Keegan Shaun Patrick¹²,Droege Molly Elizabeth¹²^ORCID,Dykes Nicole Jade Harger¹²,Ernst Neil Edward¹²,Foertsch Madeline Jane¹²,Makley Amy Teres³,Mueller Eric William¹²,Philpott Carolyn Dosen¹²^ORCID,Srinivasan Vasisht⁴,Winter Jessica Brooke¹²,Goodman Michael D.³,Droege Christopher Allen¹²

Affiliation:

1. Department of Pharmacy UC Health – University of Cincinnati Medical Center Cincinnati Ohio USA

2. University of Cincinnati James L. Winkle College of Pharmacy Cincinnati Ohio USA

3. Department of Surgery, Division of Trauma University of Cincinnati Cincinnati Ohio USA

4. Department of Emergency Medicine University of Washington School of Medicine Seattle Washington USA

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2727

Reference32 articles.

1. Current trends in the duration of anticoagulant therapy for venous thromboembolism: a systematic review;Alexander P;Cureus,2021

2. Antithrombotic Therapy for VTE Disease

3. Antithrombotic Therapy for VTE Disease

4. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

5. Reversal agents for non-vitamin K antagonist oral anticoagulants

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Pathways and Outcomes of Andexanet Alfa Administration for the Reversal of Critical Bleeding in Patients on Oral Direct Factor Xa Inhibitors;TH Open;2024-04

2. The Incidence of Thrombotic Events After the Concomitant Use of Andexanet alfa and 4-Factor Prothrombin Complex Concentrate;Hospital Pharmacy;2024-03-29

3. Co-administration of Four-Factor Prothrombin Complex Concentrate With Andexanet alfa for Reversal of Nontraumatic Intracranial Hemorrhage;Hospital Pharmacy;2024-02-16

4. The use of andexanet alpha in the Polish setting: An interdisciplinary protocol. Expert consensus statement of the Polish Cardiac Society;Kardiologia Polska;2024-01-31

5. Massive Transfusion/Hemorrhage Protocols Versus Goal-Directed Bleeding Management: Science Gone Eerie?;Journal of Cardiac Critical Care TSS;2024-01-22